Helen Chen

New Business

China’s new drug insurance: lifeline for patients or squeeze on big pharmaceutical firms?

Mainland China’s 17 million Alzheimer’s patients can, for the first time, pay less out of pocket for a costly drug…

Read More »
New Business

China’s clinical trial capacity matches US, attracts more global pharma firms, investors

China’s growing pipeline of novel drug candidates is expected to draw increased attention from global pharmaceutical companies and investors scouting…

Read More »
Back to top button